On the other hand, p62 exhibited positive correlations with several tumor-suppressive and immune-stimulatory pathways, including p53 signaling, apoptosis, interferon-α/γ responses, complement activation, allograft rejection, inflammatory response, and IL6/JAK/STAT3 signaling, in a distinct cluster of cancers. Here, TP53 is linked to cancer.